Study identifier:NIS-ODE-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An NIS Registry for the Epidemiological and Scientific evaluation of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic Non-small Cell Lung Cancer (stage IIIB/IV non-small cell lung cancer)
Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
No
-
All
4243
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2015 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|